Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Topp

Showing results (81-90 of 308) with videos related to

Pageof 31
Sort By:
Haematologica|March 15, 2006
Intravenously administered rituximab induces remission of EBV associated non Hodgkin lymphoma confined to the brain in a patient after allogeneic stem cell transplantationG Stuhler, S Knop, M S Topp, et al.
Blood|August 7, 2009
Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host diseaseClaudia Stuehler, Stephan Mielke, Manik Chatterjee, et al.
Human Gene Therapy|July 10, 2004
Enhanced transgene expression in quiescent and activated human CD8+ T cellsLaurence J N Cooper, Max S Topp, Cris Pinzon, et al.
Journal of Cancer Research and Clinical Oncology|June 4, 2021
R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvementMaximilian J Steinhardt, Franziska C Krummenast, Andreas Rosenwald, et al.
Infectious Diseases and Therapy|February 17, 2022
Efficacy and Safety of 8- or 12 Weeks of Glecaprevir/Pibrentasvir in Patients with Evidence of Portal HypertensionRobert S Brown, Michelle A Collins, Simone I Strasser, et al.
Annals of Hematology|January 31, 2012
Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 casesLeo Rasche, Corinna Bernard, Max S Topp, et al.
Cancer Research|May 15, 1995
Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologiesM S Topp, C A Papadimitriou, F Eitelbach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2002
Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cellsEisei Kondo, Max S Topp, Hans-Peter Kiem, et al.
Leukemia & Lymphoma|April 6, 2019
Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemiaHervé Dombret, Max S Topp, Andre C Schuh, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 23, 1999
N-Acetylaspartate distribution in rat brain striatum during acute brain ischemiaT N Sager, H Laursen, A Fink-Jensen, et al.
Pageof 31

Showing results (81-90 of 308) with videos related to

Sort By:
Pageof 31
Haematologica|March 15, 2006
Intravenously administered rituximab induces remission of EBV associated non Hodgkin lymphoma confined to the brain in a patient after allogeneic stem cell transplantationG Stuhler, S Knop, M S Topp, et al.
Blood|August 7, 2009
Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host diseaseClaudia Stuehler, Stephan Mielke, Manik Chatterjee, et al.
Human Gene Therapy|July 10, 2004
Enhanced transgene expression in quiescent and activated human CD8+ T cellsLaurence J N Cooper, Max S Topp, Cris Pinzon, et al.
Journal of Cancer Research and Clinical Oncology|June 4, 2021
R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvementMaximilian J Steinhardt, Franziska C Krummenast, Andreas Rosenwald, et al.
Infectious Diseases and Therapy|February 17, 2022
Efficacy and Safety of 8- or 12 Weeks of Glecaprevir/Pibrentasvir in Patients with Evidence of Portal HypertensionRobert S Brown, Michelle A Collins, Simone I Strasser, et al.
Annals of Hematology|January 31, 2012
Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 casesLeo Rasche, Corinna Bernard, Max S Topp, et al.
Cancer Research|May 15, 1995
Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologiesM S Topp, C A Papadimitriou, F Eitelbach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2002
Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cellsEisei Kondo, Max S Topp, Hans-Peter Kiem, et al.
Leukemia & Lymphoma|April 6, 2019
Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemiaHervé Dombret, Max S Topp, Andre C Schuh, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 23, 1999
N-Acetylaspartate distribution in rat brain striatum during acute brain ischemiaT N Sager, H Laursen, A Fink-Jensen, et al.
Pageof 31